Concord Medical Co., Ltd. (TPEX:6518)

Market Cap	866.67M -1.1%
Revenue (ttm)	905.31M +4.9%
Net Income	54.73M +16.4%
EPS	1.64 +16.3%
Shares Out	33.33M
PE Ratio	15.86
Forward PE	n/a
Dividend	1.10 (4.23%)
Ex-Dividend Date	Apr 10, 2025

Volume	11,160
Average Volume	11,458
Open	25.90
Previous Close	26.00
Day's Range	25.90 - 26.00
52-Week Range	22.80 - 28.40
Beta	0.34
RSI	47.42
Earnings Date	Mar 6, 2026

About Concord Medical

Concord Medical Co., Ltd. provides hospital management support services primarily in Taiwan. The company offers medical management services that include medical training and nursing staffing and assisting on medical management; and procurement services for instruments and equipment, drugs, medical materials and consumables, testing equipment, and reagents and consumables, as well as develops its own brand for medical aesthetic skincare products, health foods, and topical Chinese medicine products. It is also involved in the medical equipment pl...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6518

Financial Performance

In 2024, Concord Medical's revenue was 889.85 million, an increase of 6.80% compared to the previous year's 833.20 million. Earnings were 49.57 million, an increase of 15.97%.